Cutler Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-123
Closed -$69.1K 3505
2023
Q1
$72K Sell
123
-360
-75% -$202K 0.01% 1150
2022
Q4
$194K Buy
483
+277
+134% +$130K 0.02% 799
2022
Q3
$120K Buy
206
+174
+544% +$104K 0.01% 1257
2022
Q2
$17K Sell
32
-10
-24% -$5.06K ﹤0.01% 2781
2022
Q1
$26K Buy
42
+14
+50% +$7.22K ﹤0.01% 2813
2021
Q4
$18K Buy
28
+4
+17% +$2.43K ﹤0.01% 3197
2021
Q3
$15K Buy
+24
New +$20.5K ﹤0.01% 3573

Other funds holding AGL

Cutler Group's AGL Position: Q2 2023 in Review

Cutler Group sold out of Agilon Health (AGL) in Q2 2023, closing a stake of 123 shares — an estimated $69.1K sold.

Cutler Group first reported a position in AGL in Q3 2021 and held it in 7 quarters. The position peaked at $194K in Q4 2022. 185 funds tracked by Wall St. Rank hold AGL as of Q2 2023.

  • Cutler Group reported no remaining Agilon Health position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 123 Agilon Health shares in Q2 2023, an estimated $69.1K.
  • Cutler Group first reported a position in Agilon Health in Q3 2021 and held it in 7 quarters.
  • Cutler Group's Agilon Health position peaked at $194K in Q4 2022.
  • 185 funds tracked by Wall St. Rank held Agilon Health as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.